Migration of naïve and activated lymphocytes is regulated by the expression of various molecules such as chemokine receptors and ligands. CD69, the early activation marker of C-type lectin domain family, is also shown to regulate the lymphocyte migration by affecting their egress from the thymus and secondary lymphoid organs. Here, we aimed to investigate the role of CD69 in accumulation of CD4 T cells in intestine using murine models of inflammatory bowel disease. We found that genetic deletion of CD69 in mice increases the expression of the chemokines CCL-1, CXCL-10 and CCL-19 in CD4
Introduction
In the intestinal immune system chemokine ligands and receptors regulate the migration of lymphocytes. Naïve cells express high levels of L-selectin (CD62L) and chemokine receptor CCR-7 that recognize secondary lymphoid organs (SLO)-expressed addressin and the chemokines CCL-19 and CCL-21, respectively [1, 2, 3] . Lymphocyte egress from the SLO depends on the expression of sphingosine 1-phosphate receptor type 1 (S1P 1 ) on the lymphocyte surface and its interaction with the ligand sphingosine 1-phosphate (S1P) that is abundant in the lymph [4, 5] . Activated lymphocytes express different combinations of chemokine receptors depending on their migration destination and the subtype they differentiate to. For example Th1 cells express CXCR-3 (binding CXCL-10) [6] , Th17 cells express CCR-6 (binding CCL-20) [7] while CCR-8 (binding CCL-1) is implicated in Th2 responses but studies showed its expression primarily on the memory cells of Th2 subtype and Foxp3 regulatory (Treg) cells [8] . Lymphocytes that migrate from the SLO to the gut express the chemokine receptor CCR-9 and the integrin a4b7 that bind CCL-25 and mucosal addressin cell adhesion mlecule-1 (Mad-CAM-1), respectively [1, 2] .
Inflammatory bowel disease (IBD), such as Crohn's disease (CD) and ulcerative colitis (UC) are thought to be the product of a deregulated immune response to constituents of the intestinal microflora. The migration of lymphocytes to the lamina propria seems to be a key event for the pathogenesis of IBD. Strategies that block the recruitment of leukocytes into the intestine represent a potentially potent treatment of IBD. The anti-a4 mAb was efficient in the treatment of CD [9] but it increases the susceptibility to any infection showing the need for tissue specific migration inhibitor. FTY-720 (fingolimid) as the agonist of S1P receptor family was very effective in the animal models of IBD [10, 11] , but it showed the side effect of bradycardia in the clinical trials [12] due to expression of S1P 3 receptor on myocard [13] . Studies are now being conducted with the agonists specific only for S1P 1 receptor expressed exclusively on lymphocytes [13] and some of them are promising in the IBD treatment [14, 15] . Also the mAb to CXCL-10 as the agent that specifically inhibit the migration of Th1 cell subset, is in the clinical trials for the treatment of UC [9] .
The C-type lectin receptor CD69 (encoded in NK gene cluster) is the earliest activation antigen of lymphocytes. This molecule is shown to be involved in the regulation of immune responses in murine models of asthma [16, 17] , arthritis [18, 19] , colitis [20] , myocarditis [21] , pathogen clearance [22] and tumors [23, 24] . CD69 activation induces TGF-b expression and suppresses the production of pro-inflammatory cytokines IL-17 and IFN-c [19, 20, 23, 25, 26] . Studies showed that activation of CD69 leads to ERK phosphorylation and thus stabilizes TGF-b on the cell surface of lymphocytes [27] . After allogenic bone-marrow transplantation CD4
+ CD69 + CD25 2 T cells protect from the development of graft-versus host disease [28] . CD69 + T cells are able to induce indoleamine 2,3-dioxygenase (IDO) in tumorassociated macrophages and hence down-regulate inflammatory immune responses [29] . Therefore CD4 + CD69 + CD25 2 T cells have been introduced as novel regulatory cell type whose effector functions depend mainly on TGF-b.
Besides regulating the cytokine response, CD69 has also been shown to affect the migration of immune cells. Constitutive overexpression of CD69 in transgenic animals implicated a role of this molecule in releases of lymphocytes from the thymus [30, 31] . Furthermore, CD69 directly interact with S1P 1 receptor on the lymphocyte surface inducing the down-regulation of S1P 1 expression [32, 33] . Consequently, CD69 mediates the retention of activated lymphocytes in the SLO [4, 32] . The migration of dendritic cells (DC) from the skin to draining lymph nodes is increased in CD69-deficient animals [34] . Overall, these studies suggested an important role of CD69 in regulating the migration of lymphocytes, but the molecular mechanism of this effect is not completely solved.
This study showed that CD69-deficiency increases CCL-1, CXCL-10 and CCL-19 expression. CD69-defiecient CD4 T cells migrated rapidly toward the chemokine gradient in vitro and accumulated in the intestinal tissues in vivo. Furthermore, CD69 2/ 2 animals showed increased fraction of naïve and decreased fraction of memory CD4 T cells compared to B6 animals. Absence of CD69 induced severe intestinal inflammation in DSS-induced colitis and antigen-specific transfer colitis. Severity of the colitis could be ameliorated in DSS-administrated CD69-deficeint mice with the neutralization of CCL-1, CXCL-10 and CCL-19. These data indicated that CD69 is an important regulator of immune responses that regulates the expression of chemokines and cell accumulation during intestinal inflammation.
Materials and Methods

Mice
Inbred C57BL/6J (B6) mice, RAG 2/2 (RAG tm1Mom ), CD69 [36] were bred and kept under specific pathogen-free (SPF) conditions in the animal facility of Ulm University (Ulm, Germany). Female and male mice were used at 6-12 weeks of age. The local animal committee (Regierungsprä sidium Tübingen) approved the animal protocols (protocol no. #1010, #1067 and #1089). All animal experiments were performed according to the guidelines of the local Animal Use and Care Committee and the National Animal Welfare Law.
Dextran Sodium Sulphate (DSS)-induced Colitis
B6 and CD69
2/2 mice were fed 2% DSS salt (cat. no. 160110; MP Biomedicals, Illkirch, France) dissolved in sterile water ad libitum for five days. On day 5, DSS containing water was removed and replaced with normal sterile water. In one experiment mice were treated with chemokine antagonists (anti-CCL-1 Ab 148113 (cat. no. MAB845), anti-CXCL-10 Ab 134013 (cat. no. MAB466) and anti-CCL-19 Ab 87201 (cat no. MAB880) all purchased from R&D Systems, Wiesbaden, Germany). The mixture of the respective anti-chemokine Abs was injected i.p. on days 0, 2, 4 and 6 after DSS administration with the concentration of the individual Ab being 1 mg/kg. The weight of mice and their clinical condition were monitored daily. Mice were sacrificed at day 3 or at the peak of disease, at day 7 after DSS administration. Tissue samples for histopathological examination were taken from the large intestine, fixed in neutral-buffered formalin, embedded in paraffin, sectioned on a microtome, mounted on slides, and stained with hematoxylin and eosin (H&E). Histology of the large intestine was categorized as normal (score 0); mild colitis (score 1), with few inflammatory cells in the lamina propria (LP), stromaedema, and a slight reduction of goblet cells; moderate colitis (score 2), with an intense inflammatory infiltration of the LP, hyperplasia of crypts, and a marked reduction of goblet cells; or severe colitis (score 3), with a spillover of leukocytes beyond the mucosa into deeper layers of the colonic wall, complete loss of goblet cells, distortion of the mucosal architecture, erosions or ulcerations, and crypt abscesses as previously published [20, 37, 38] .
Antigen-specific Transfer Colitis Model
Total spleen cells of OT-II or OT-II6CD69
2/2 mice were isolated and stained for CD4 and CD45RB with FITCconjugated mAb binding CD4 GK1.5 (cat. no. 11-0041-86; eBioscience, Frankfurt, Germany) and biotinylated mAb binding CD45RB 16A (cat. no 553093; BD Biosciences, Heidelberg, Germany), followed by the second-step reagent StreptavidinPeridinin Chlorophyll Protein (PerCP)-Cy5.5 (cat. no. 45-4317-80; eBioscience). CD45RB high T cells from the CD4 + population were enriched using the FACSAria system (BD Biosciences) to a purity .95%. Purified CD45RB high CD4 T cells were injected i.p. into RAG 2/2 mice (3610 5 cells/mouse). Hosts were fed or not intragastrically every second day with 1 mg of chicken ovalbumin (OVA) protein (cat. no. A5253; grade II, Sigma-Aldrich, Steinheim, Germany) dissolved in 100 ml of PBS. The weight of transplanted mice and their clinical condition were monitored twice weekly. Tissue samples for histopathological examination were taken from the large intestine, fixed in neutral-buffered formalin, embedded in paraffin, sectioned on a microtome, mounted on slides, and stained with H&E. Histological scoring was preformed same as described above for the DSS colitis model.
In vitro Chemokine Receptor Functionality Assay
Chemokine stocks were made in PBS supplemented with 0.1% of BSA and diluted in RPMI medium containing 10% FBS and 1% Penicillin/Streptomycin when used for experiments. Concentrations of CCL-1 (cat. no. 845-TC; R&D Systems), CXCL-10 (cat. no. 466-CR; R&D Systems), CCL-5 (cat. no. 478-MR; R&D Systems) and CCL-4 (cat. no. 451-MB; R&D Systems) were titrated (from 0.5 nM to 200 nM) and 600 ml of only medium or medium containing chemokine was added in the lower chamber of 24-well transwell system with 5 mm pore size polycarbonate membrane (cat. no. 3421; Corning, New York). This membrane does not allow the medium to diffuse, but allows T cells to migrate from one chamber to another. After loading the lower chamber, inserts containing the membrane were carefully placed into the wells. CD4 T cells were enriched from the total spleen cells of B6 and CD69 2/2 mice using the MACS CD4 T cell isolation kit (cat. no. 130-090-860; Miltenyi Biotec, Bergisch Gladbach, Germany). 4610 5 B6 or CD69 2/2 CD4 T cells in 100 ml of RPMI, 10% FBS, 1% Penicillin/Streptomycin medium were added to the upper chambers. Plate was covered and incubated 1 hour at 37uC, 5% CO 2 . Transwell inserts were carefully removed and cells in the lower chamber media counted by FACSCalibur. All reactions were done in at least four repeats. The chemotactic index was calculated as: the number of cells migrating to the media with chemokine divided by the average number of cells migrating to the media alone as previously described [39] . [39] this index was normalized to the HI in the blood to eliminate possible retention of the one cell type in some of the secondary lymphoid tissues which could eliminate that cell type from the circulation.
In vivo
In a separate experiment 1610 7 of each cell population in 200 ml PBS were i.v. injected to one B6 mouse. 18 h post-injection small intestine and colon were isolated and washed from faeces with PBS/1% FBS using tubing needle. Washed small intestine and colon were incubated for 1 h at room temperature in dark with Alexa Fluor 350-conjugated Wheat Germ Agglutinin (WGA, cat. no. W11263; Invitrogen), 20 mg/ml final concentration, in 1 ml PBS/1%FBS. WGA binds mucus glycoproteins in the intestine [40] staining for the surface of intestinal epithelium. Small intestinal and colonic tissues were analyzed by LSM 710 Confocal Laser Scanning Microscope (Zeis, Jena, Germany) and different fluorescent colours were detected using following excitation/emission spectra: for Alexa Fluor 350 350 nm/408-464 nm, for DsRed 512 nm/591-715 nm and for CFSE 488 nm/ 493-525 nm. Pictures were obtained at the original magnification 40x/1.30 oil DIC M27 and were analyzed using LSM Image Browser software (Zeis, Jena, Germany).
Antigen-specific in vivo Competitive Homing Assay
CD4 T cells from the spleen of OT-II6DsRed or OT-II6CD69
2/2 mice (both on Vb5 + background) were enriched by MACS and OT-II6CD69 2/2 CD4 T cells were labelled with CFSE by the protocol described in previous section. OTII6DsRed and CSFE + OT-II6CD69 2/2 CD4 T cells were mixed in a 1:1 ratio and 10 6 of each cell population in 200 ml of PBS were i.v. transferred to B6 hosts. A small amount of cells was saved after injection for calculating IR. These cells were extracellulary stained for CD4 with APC-conjugated mAb binding CD4 GK1. 5 
Microarray Data
Gene expression data of B6, CD69-activated B6 and CD69
2/2
CD4 T cells have analyzed as previously described by our group [20] . These data are accessible at NCBI GEO database (GEO; accession number GSE27706).
CD4 T cell Isolation
CD4 T cells were isolated from the blood, cLP, siLP, spleen and MLN of B6, CD69 2/2 , DsRed, OT-II, OT-II6CD69 2/2 , OTII6DsRed and CD45.1 B6 mice.
Isolation of blood cells. Arterial blood was obtained from the mice, mixed with EDTA as anti-coagulant and red blood cells were lysed by 3 times 5 min incubation on 37uC with 5 ml of Lysebuffer (0.16 M NH 4 Cl and 0.17 M Tris, pH 7.2) followed by washing with PBS/1%FBS.
Isolation of spleen and MLN cells. Single-cell suspensions were aseptically prepared from spleen and MLN and red blood cells from spleen were lysed by 10 min incubation on 37uC with 5 ml of Lysebuffer. All the cells were washed and resuspended in PBS supplemented with 1% FBS.
Isolation of small intestinal and colonic lamina propria cells. Segments of the small intestine or colon were washed with PBS to remove debris and mucous. The epithelium was removed by incubation at 37uC for 10-15 min under gentle shaking with 1 mM dithiothreitol (and 1 mM EDTA for colon tissue) in 25 ml PBS supplemented with 1% FBS. The remaining tissue was washed in PBS to remove residual epithelial cells, and the supernatants were discarded. Intestinal tissues were cut into 262-mm pieces and digested by incubation with 0.25 mg/ml collagenase type VIII from Clostridium histolyticum (cat. no. C-2139; Sigma-Aldrich, St. Louis, MO) for 30-45 min at 37uC in RPMI 1640 under shaking. Supernatants were collected, from which LP lymphocytes were pelleted. LP lymphocytes were resuspended in RPMI 1640 medium containing 35% Percoll (density 1.124 g/ml;
cat. no. L-6145; Biochrome, Berlin, Germany). This cell suspension was overlaid onto 70% Percoll and centrifuged for 20 min at 7506g. Viable cells at the 35%/70% Percoll interface were collected and washed twice.
Extracellular Staining
Cells were washed twice in PBS supplemented with 0.3% BSA and 0.1% sodium azide. Non-specific binding of antibodies to Fc receptors was blocked by preincubation of cells with mAb 2.4G2 (cat. no. 01241D; BD Biosciences) directed against the FccRIII/II CD16/CD32 (0.5 ng mAb/10 6 cells). Cells were washed and incubated with 1 ng/10 6 cells of the relevant mAb for 20 min at 4uC and washed again twice. In some experiments, cells were subsequently incubated with 1 ng/10 6 cells of the second-step reagent for 20 min at 4uC. The following antibodies were used: APC-conjugated mAb binding CD4 GK1. 5 
Intracellular Foxp3 Staining
Cells were isolated, washed with PBS supplemented with 0.3% BSA and 0.1% sodium azide and stained extracellularly with FITC-conjugated anti-CD4 mAb binding CD4 GK1.5 (cat. no. 11-0041-86; eBioscience). Surface-stained cells were than pelleted and resuspended in 200 ml of Fixation/Permeabilization buffer (cat. no. 00-5123-43; eBioscience). After overnight incubation at 4uC in the dark, cells were washed two times with 16Permeabilization buffer (cat. no. 00-8333-56; eBioscience) and incubated for 15 min, 4uC with mAb 2.4G2 directed against the FccRIII/II CD16/CD32 (0.5 ng mAb/10 6 cells) for preventing non-specific binding of the Abs. Cell were pelleted and after discarding the supernatant incubated for 30 min at 4uC, dark with 0.5 ng/10 6 cells of the PE-conjugated anti-Foxp3 FJK-16s (cat. no. 12-5773-80; eBioscience) mAb diluted in 16Permeabilization buffer. Stained cells were washed once with 16Permeabilization buffer, once with PBS supplemented with 0.3% BSA and 0.1% sodium azide, resuspended in PBS supplemented with 0.3% BSA and 0.1% sodium azide and analyzed on FCM.
Cytokine Detection by ELISA
The concentration of IL-17 in the blood serums was measured by a conventional double-sandwich ELISA. Capture mAb TC11-18H10 (cat. no. 555068) and detection biotinylated mAb TC11-8H4.1 (cat. no. 555067) were purchased from BD Bioscience. Extinction was measured at 450 nm on a TECAN microplate-ELISA reader using EasyWin software (both from Tecan, Wetzlar, Germany). 
Chemokine and Cytokine Expression Analyses by qRT-PCR
Statistics
We performed Mann-Whitney test for assessing the difference of two samples and one-sample t-tests for testing the deviation from the theoretical mean (GraphPad Prism V4). The difference between data sets of three and more groups was analyzed with Kruskal-Wallis test and Mann-Whitney as post-hoc test (GraphPad Prism V4). P#0.05 was considered statistically significant.
Results
Increased Expression of Chemokines in the Absence of CD69
To identify transcripts differentially regulated by the CD69 activation marker in CD4 T lymphocytes we carried out microarray analysis. We compared gene expression profiles of 3 groups: anti-CD3/CD28 activated B6 CD4 T cells; anti-CD3/ CD28 activated CD69 2/2 CD4 T cells and anti-CD3/CD28 activated B6 CD4 T cells on which surface CD69 molecule was activated by cross-linking. CD69 regulated the expression of chemokines as we observed the significant differences between our groups. Activation of CD69 significantly reduced the expression of XCL-1, CCL-4, CCL-1, CCL-9, CCL-3, CXCL-9 and CXCL-10 chemokine and CCR-8, CCR-4, CCR-5 chemokine receptor transcripts in B6 CD4 T cells as compared to CD69 2/2 CD4 T cells ( Table 1 ). The expression of most chemokines was reduced in CD69-activated B6 CD4 T cells when compared to B6 CD4 T cells, but increased in CD69 2/2 as compared to B6 CD4 T cells (Table S1 and Table S2 ).
To analyse if CD69 affects the expression of chemokines in vivo, we conducted qRT-PCR analyses. In absence of CD69 an increased expression of CCL-1, CXCL-10 and CCL-19 genes was observed in mesenteric lymph nodes (MLN), small intestinal (si) and colonic (co) tissues (Fig. 1A-C) . To identify the cell source of increased chemokine production, RNA was isolated from CD4 + and CD4
2 cells of B6 and CD69 2/2 mice, reverse transcribed to cDNA and analysed by qRT-PCR. Confirming the micro-array data, increased expression of CCL-1 and CXCL-10 was found in CD69 2/2 CD4 + T cells (Fig. 1D,E) . CD69 2/2 CD4 2 cells showed increased expression of CCL-1 and CCL-19 but not of CXCL-10 gene (Fig. 1D-F) . However, no significant difference in expression of CCL-5 and CCL-8 was observed (Fig. S1) . These data indicated that CD69 negatively regulates the expression of
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+ and CD4 2 cell populations.
CD69 Regulates the Migration of CD4 T cells Toward the Chemokine Gradient in vitro
As CD69 regulated the expression of chemokines, we investigated if CD69-deficiency affects the response of CD4 T cells toward the chemokine gradient in vitro. In this assay we used the transwell system with the polycarbonate membrane that prevents the diffusion of medium, but allows the migration of CD4 T cells in between the chambers. The lower chamber contained pure medium or the medium with titrated concentrations of chemokine. Upper chamber was filled with medium containing B6 or CD69 2/2 spleen CD4 T cells. After 1 h incubation at 37uC, 5% CO 2 the number of cells that migrated to the lower chamber was counted by FCM. There was no difference in the number of B6 and CD69 2/2 CD4 T cells migrating to the medium alone ( Fig. 2A) . When CCL-1, CXCL-10 or CCL-5 were added to the medium significantly increased numbers of CD69-deficient as compared to B6 CD4 T cells were migrating toward the chemokine gradient for most of the chemokine concentrations tested (Fig. 2B-D) . Chemotactic index represents the number of cells counted in the medium containing the chemokine normalized to the mean cell number counted in the pure medium and it was calculated for every chemokine concentration used. CD69 2/2 CD4 T cells showed significantly increased chemotactic index for CCL-1, CXCL-10 and CCL-5 ( Fig. 2E-G) . Increased migration of CD69-deficient CD4 T cells toward CCL-1 and CCL-5 correlated with increased expression of the respective chemokine receptors for these chemokines, CCR-8 and CCR4/CCR5, respectively (Table S2 ). Significant differences between B6 and CD69 2/2 CD4 T cells were not observed when the chemokine CCL-4 (another CCR4/CCR5 ligand) was used in our experiments (Fig. 2E,I ). The expression of the CXCL-10 receptor, CXCR-3, by CD69 2/2 CD4 T cells was not increased (Fig. S2) . Thus, CD69-deficiency increases the chemokine-dependent migratory potential of CD4 T cells toward some, but not all chemokines.
CD69 Regulates the Homing of CD4 T cells to the Intestinal Tissues in vivo
To compare the migration pattern of B6 and CD69 
CD69
2/2 cells among the CD4 + CD45.2 + cell population were determined by FCM. 18 h after transfer the number of B6 and CD69-deficient CD4 T cells in the blood was the same while in MLN, siLP and cLP the number of CD69 2/2 CD4 T cells was significantly increased (Fig. 3A) . These results are confirmed for small intestinal and colonic tissue by ex vivo confocal imaging as we observed higher number of green CD69 2/2 than red B6 CD4 T cells in both tissue samples (Fig. 3C) . 72 h after the cell transfer significantly increased numbers of CD69-deficient cells were found in the intestinal tissues but also in blood (Fig. 3D) . Possible retention of B6 CD4 T cells in some of the organs non-analysed here could contribute to the observed results. To eliminate this effect of tissue cell retention, we expressed the results of this assay also as homing index (HI). HI for intestinal tissues were calculated as the ratio of CD69 2/2 to the B6 CD4 T cell number recovered from the hosts normalized to the IR of the injected cells and also normalized to the blood HI. This analyzes showed that 18 h posttransfer CD69 2/2 CD4 T cells have an increased potential to migrate to the siLP and cLP, but not to MLN (Fig. 3B) . 72 h after the cell transfer CD69-deficient CD4 T cells had a reduced potential to migrate to the MLN and same potential to migrate to siLP and cLP when compared to B6 CD4 T cells (Fig. 3E) . This assay showed that CD69-deficient CD4 T cells migrate more efficiently than B6 cells to the intestinal tissues at early, but not late time point.
Cells on OT-II background showed slightly different migratory behaviour in this assay. 72 h after the DsRed OT-II/CFSE + OT-II6CD69 2/2 CD4 T cells were transferred into hosts, no difference in cell number could be observed in any tissue analysed (Fig. S3) . When transferred mice were fed the specific antigen, OVA, increased number of CD69-deficeint OT-II CD4 T cells was found in siLP (Fig. S3) . This means that homing of OT-II CD4 T cells to intestinal tissues depends not only on CD69, but also on presence of the antigen.
CD69 Regulates Naïve/memory Cell Ratio in CD4 T cell Population
Different migration patterns of B6 and CD69 2/2 CD4 T cells observed in vivo could be the consequence of different expression of naïve and memory surface cell markers. Therefore, we investigated by FCM the expression of these markers on B6 and CD69 2/2 CD4 T cells. Absence of CD69 significantly reduced the expression of memory cell markers in CD4 T cell population: CD44 in all tissues tested except of blood and CD103 in spleen and siLP (Fig. 4A,B) . On the other hand, the expression of CD62L, marker of naïve cells and the chemotactic receptor that regulates the migration to lymph nodes and intestine, was increased in spleen, MLN and siLP of CD69 2/2 mice (Fig. 4C) . The expression of another naïve cell marker, CCR-7, did not significantly differ between B6 and CD69 2/2 CD4 T cells (Fig. 4D) . The expression of CCR-9, an intestine homing marker, was increased only in the spleen of CD69-deficient mice (Fig. 4E) , while no differences were observed in the expression of a4b7 (Fig. 4F) . These data indicated that the expression of main intestine homing markers is generally not affected by CD69. However, CD69 regulates naïve/memory cell ratio with CD69 2/2 mice having a reduced fraction of memory CD44
+ and CD103 + CD4 T cells and increased fraction of naïve CD62L + CD4 T cells.
Severe Colitis Induced in CD69 2/2 Mice after the DSS Administration Depends on Increased Accumulation of CD4 T cells in cLP Attracted by CCL-1, CXCL-10 and CCL-19
Administration of 2% DSS in the drinking water induced severe colitis in CD69-deficient mice as observed by the accelerated body weight loss compared to the DSS treated B6 animals and nontreated control group (Fig. 5A) . Severity of intestinal inflammation is evaluated by histopathological examination of the colon. Average colitis score was significantly increased in the group of DSS-treated CD69 2/2 mice when compared to the DSS-treated B6 and non-treated control groups (Fig. 5B) . Colonic tissue of the control mice showed normal architecture and cellularity on the histological slides, while after the DSS treatment in B6 animals the signs of mild inflammation were observed (Fig. 5C ). In CD69
mice a massive infiltration of inflammatory cells and the los of tissue architecture confirmed the severity of the disease (Fig. 5C ).
Relative quantification of gene expression by RT-PCR was conducted using the RNA isolated from the frozen tissue sections of proximal colon taken from DSS administrated B6 and CD69 2/ 2 mice and non-treated control animals. These analyzes revealed significant increase in the expression of CCL-1, CXCL-10 and CCL-19 in the inflamed colon tissue of DSS-treated CD69 2/2 mice when compared to the other experimental groups (Fig. 5D-F) .
The treatment of DSS-induced colitis in CD69
2/2 mice with the mixture of Abs that neutralize CCL-1, CXCL-10 and CCL-19 did not affect the accelerated body weight loss (Fig. 5A) , but it reduced significantly the histopathological severity of the disease (Fig. 5B) . CD69-deficient animals treated with neutralizing Abs showed the signs of mild colitis, with normal number of goblet cells, slightly elongated colonic crypts and few infiltrating inflammatory cells (Fig. 5C) . Severe colonic inflammation with infiltration of high number of inflammatory cells into the colonic wall observed in CD69 2/2 mice after DSS administration could be caused by the increased expression of pro-inflammatory chemokine ligands.
High pro-inflammatory Cytokine Response and Early Influx of CD4 T cells Devoid of Foxp3 Treg Cells into cLP are Observed in DSS-treated CD69
2/2 Mice
To investigate the influence of the factors other than chemokines in DSS colitis model, we analyzed expression/ production of pro-inflammatory cytokines as well. We saw that DSS-administrated CD69-deficient mice have significantly increased serum level of IL-17 as compared to the DSS-treated B6 and non-treated control group (Fig. 6A) . Also, expression of the gene encoding pro-inflammatory cytokine IFN-c was increased in the colonic tissue of the CD69 2/2 animals treated with DSS CD4 T cells were enriched from the spleen of B6 or CD69 2/2 mice and migration of these cells was analysed in vitro in transwell system. Medium alone or containing indicated concentrations of CCL-1, CXCL-10, CCL-5 and CCL-4 were loaded in the lower chamber of the transwell system, while CD4 T cells in the medium were loaded in the upper chamber. Cell number migrating from the upper chamber to the chemokine containing chamber trough polycarbonate membrane after 1 h at 37uC, 5% CO 2 was counted by flow cytometry. All the reactions were done in at least four repeats and average cell number per chemokine concentration per cell type was calculated. Results are presented as the number of cells migrating to the wells containing medium alone (A) or indicated concentration of CCL-1 (B), CXCL-10 (C), CCL-5 (D) or CCL-4 (E). Mean (6 SEM) for at least four repeats per each chemokine concentration and cell type is presented. The lower graph set represents chemotactic indexes of B6 and CD69 2/2 CD4 T cells for CCL-1 (F), CXCL-10 (G), CCL-5 (H) and CCL-4 (I). The chemotactic index was calculated as: the number of cells migrating to the media with chemokine divided by the average number of cells migrating to the media alone. *p#0.05. doi:10.1371/journal.pone.0065413.g002 (Fig. 6B) . Furthermore, three days after the DSS administration CD69 2/2 mice had reduced number of CD4 T cells in MLN and increased number of these cells in cLP when compared to B6 animals (Fig. 6C) . Further analyses of these CD4 T cells showed that 3 days after the DSS administration CD4 T cell population in cLP of CD69-deficient mice contained significantly reduced fraction of Foxp3-expressing Treg cells compared to B6 mice, while in blood and MLN there was no difference (Fig. 6D,E) . This early influx of CD4 T cells devoid of Treg cells together with the increased levels of pro-inflammatory cytokines contribute to the severe pathology observed in the colon of CD69 2/2 mice treated with DSS.
OT-II6CD69 2/2 CD4 T cells Accumulate in cLP During Transfer Colitis Model
Antigen-specific transfer colitis model was established to study the inflammatory response of CD4 T cells in the presence or absence of specific antigen in intestinal lumen. CD45RB high CD4 T cells were sorted from the splenocytes of OT-II or OT-II6CD69 2/2 mice and adoptively transferred into the RAG 2/2 hosts. After the transfer hosts were fed or not every second day with 1 mg OVA protein. Both groups fed with OVA developed colitis, but the disease was more severe in the hosts transferred with OT-II6CD69 2/2 cells and fed with OVA as showed by accelerated body weight loss compared to all the other groups (Fig. 7A) and by severe histopathology in colon (Fig. 7B,C) . The hosts transferred with OT-II or OT-II6CD69 2/2 CD45RB high CD4 T cells that were not fed with OVA, normally gain body weight as the control group (Fig. 7A) , although OT-II6CD69 2/2 cell-transferred mice showed more severe histopathology in colonic tissue (Fig. 7B,C) . Total number of OT-II CD4 T cells in cLP of the hosts was significantly increased compared to the control in the presence of antigen (Fig. 7D) . The number of cLP OT-II6CD69 2/2 CD4 T cells was increased significantly in both groups fed or not fed with OVA when compared to the control group (Fig. 7D) . These data indicated that the accumulation of OT-II CD4 T cells in cLP is CD69-dependent in antigen-specific transfer model of colitis.
Discussion
The data presented in this study indicated that the activation marker CD69 is involved in the regulation of chemokine expression. CD69-deficient mice showed increased transcript levels of some chemokine genes, such as CCL-1, CXCL-10 and CCL-19 in steady-state conditions and after colitis induction. We saw that CD69 regulates the expression of chemokine genes in both CD4
+ and CD4 2 cells. The portion of chemokines secreted by CD4 + T cells is considered to be minor, but it can still be important for the functions of immune cells [41, 42] . In vitro chemotactic assay showed that CD69 2/2 CD4 T cells respond more efficiently to the chemokine stimuli compared to B6 CD4 T cells. This could be the result of increased chemokine receptor 2/2 mice, control and CD69 2/2 +Ch-block groups. Mean (6 SEM) for at least five mice per group are presented. C. Histopathological colon tissue samples taken from control B6 mice, DSS treated B6 or CD69 2/2 animals and CD69 2/2 +Ch-block group were embedded in paraffin, sectioned on a microtome, mounted on slides, and stained with H&E. Representative images of one individual mouse per group (from at least five mice per group analyzed) are shown (original magnification620). RNA was isolated from the frozen colon tissue samples of control B6 animals and DSS treated B6 or CD69 2/2 mice and reverse transcribed to complementary DNA. Relative expression of CCL-1 (D), CXCL-10 (E) and CCL-19 (F) genes compared to b-actin gene is measured by qRT-PCR. Mean (6 SEM) for at least five mice per group are presented. N.S. -not statistically significant; *p#0.05; **p#0.005. doi:10.1371/journal.pone.0065413.g005
after adoptive cell transfer into hosts. This could be explained by very efficient response to chemokine attraction or by increased expression of CCR-9 and CD62L by splenic CD69 2/2 CD4 T cells used in this assay. CCR-9 is a well defined intestinal homing receptor [43, 44] while CD62L regulates lymphocyte homing to peripheral lymph nodes [45] and binds also to MadCAM-1 expressed in the intestine [46] ; possible these molecules may be involved in the results we observed in in vivo competitive homing assays. This assay also showed that at later time points CD69 2/2 cells have reduced homing index to MLN and that they are abound in the blood. This could be the result of their inability to down-modulate S1P 1 receptor and stay in the lymphoid organs. Feeding the hosts with specific antigen after the cell transfer resulted in the increased migration of CD69 2/2 CD4 T cells to the siLP, the place where antigen was located. Therefore, the presence of specific antigen is also important in CD4 T cell homing to the intestine. Possible differences in cell proliferation and retention, especially at later time points, and also possible effect of different fluorescent markers (DsRed and CFSE) on cell migration cannot be excluded in this assay.
Recently CD69 has been recognized as a marker of tissue resident memory T cell population [47, 48, 49, 50] . In this study we showed for the first time that CD69 2/2 mice have decreased fraction of CD44 + and CD103 + memory CD4 T cells in peripheral tissues. These data confirmed that CD69 is important for the development of peripheral memory cell pool. Furthermore, disturbed naïve/memory cell ratios can change the migratory pattern of CD4 T cells and can be one of the factors contributing to the effects observed in this study.
Using two different colitis models we showed that CD69 2/2 CD4 T cells accumulate preferably in the cLP under the inflammatory conditions. In DSS colitis model this was at least +OVA groups were embedded in paraffin, sectioned on a microtome, mounted on slides, and stained with H&E.
The Role of CD69 in CD4 T Cell Migration partially dependent on the increased expression levels of the chemokines CCL-1, CXCL-10 and CCL-19 in the colon of CD69-deficient animals, as neutralization of these three chemokines significantly improved the histopathological picture in colon. However, the chemokine-blocking treatment did not affect the body weight loss in DSS colitis model, indicating that other factors such as increased production of pro-inflammatory cytokines and decreased cLP Foxp3 Treg cell fraction play an important role in the disease development. In antigen specific colitis model OT-II6CD69 2/2 CD4 T cells accumulated in cLP with or without antigen presence showing that this effect is only CD69-dependend. However, it is not clear weather this accumulation is a result of cell migration or proliferation, as the effect of CD69 on cell proliferation is not known.
Our study provides first evidence that CD69 does not regulate the lymphocyte migration only by influencing S1P 1 expression, but also by regulating the expression of chemokines and naïve/ memory T cell markers. We also showed that absence of CD69 leads to the accumulation of CD4 T cells in the intestinal mucosa. We hypothesize that in physiological conditions the up-regulation of CD69 on activated CD4 T cells in the intestine acts as a negative feedback mechanism to prevent the excessive inflammation by reducing the amounts of produced pro-inflammatory chemokines and cytokines and by increasing the fraction of Foxp3 Treg cells and memory cells. Our study indicated that CD69 regulates the immune system in very complex ways and showed the need for further studies that will determine the mechanisms by which CD69 regulates the functions of lymphocytes. 
Supporting Information
